Mass Spectrometry & Proteomics news

<p>Marta Vilaseca, IRB Barcelona</p>
17 Apr 2018

The latest Meet Our Scientists series is devoted to Marta Vilaseca, manager of the Mass Spectrometry & Proteomics Core Facility at IRB Barcelona.

The video "Proteins caught in fraganti" presents her specialised field.

<p>Illustrative image of how scientists have deciphered the covalent nature of beta-amyloid dimers, an article published in Analytical Chemistry. Authors: Marina Gay, IRB Barcelona, and Lorena Markovich</p>
17 Apr 2018

A study headed by IRB Barcelona provides the first direct evidence of beta-amyloid dimers (two proteins joined together) in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers.

Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.

<p>From right to left: Marina Gay, Marta Vilaseca, Mar Vilanova, Laura Villareal, Mireia Díaz-Lobo.</p>
27 May 2016

IRB Barcelona steps into High-Throughput Proteomics. After passing an external evaluation, the Mass Spectrometry Core Facility has been renamed “Mass Spectrometry and Proteomics Core Facility”. Its mission is “to apply advanced proteomic methods to help researchers study diseases, pathways, targets and drugs effects,” says Core Facility manager Marta Vilaseca, who emphasises the contribution of her team to cutting-edge research at the Institute.

The facility has recently been enlarged and now occupies an additional area in the PCB to host a new Orbitrap Fusion Lumos, which has just been installed and is fully...